Our study revealed that low-dose CYP treatment induced nerve injury in the bladder, which leading to pain in the lower abdomen and overactive bladder in female rats, and the up-regulation of mRNA expression levels of Nlrp6 and Casp11 may promote these pathological changes. Here, SCAF11 is linked to overactive bladder.